WCG Clinical, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| WCG Clinical, Inc. | WCGC - NASDAQ |
Postponed | $0.00 | $0.00 | Postponed | 8/5/2021 |
| Goldman Sachs, Morgan Stanley, BofA Securities, Barclays, Jefferies, William Blair, BMO Capital Markets, UBS Investment Bank, SVB Leerink HSBC | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-07-01 Terms Added 2021-07-27 | ||||||
About WCG Clinical, Inc. (adapted from WCG Clinical, Inc. prospectus):
They believe we are a leading provider of clinical trial solutions, focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They believe we are a leading provider of clinical trial solutions, focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "WCGC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.